Table 4. Median number of days’ wages needed to purchase standard treatments, by World Bank Income Group.
World Bank Income Group | Therapeutic group | Median days’ wages* | |||
---|---|---|---|---|---|
Public sector | Private sector | ||||
Originator brand | Lowest priced generic | Originator brand | Lowest priced generic | ||
Low-income countries (n = 10) | Cardiovascular | 1.9 (n = 4) | 0.6 (n = 28) | 2.9 (n = 11) | 0.9 (n = 38) |
Diabetes | 2.9 (n = 2) | 0.9 (n = 9) | 5.3 (n = 6) | 1.1 (n = 15) | |
COPD | 0.9 (n = 2) | 0.7 (n = 9) | 2.9 (n = 8) | 1.3 (n = 14) | |
CNS | 1.1 (n = 2) | 0.4 (n = 15) | 1.3 (n = 6) | 1.1 (n = 28) | |
All medicines | 1.1 (n = 10) | 0.7 (n = 61) | 3.1 (n = 31) | 1.0 (n = 95) | |
Lower-middle income countries (n = 12) | Cardiovascular | 2.8 (n = 7) | 0.7 (n = 58) | 3.7 (n = 31) | 1.1 (n = 85) |
Diabetes | 3.3 (n = 4) | 0.6 (n = 16) | 3.8 (n = 13) | 1.4 (n = 24) | |
COPD | 2.4 (n = 6) | 1.4 (n = 10) | 2.5 (n = 13) | 1.7 (n = 18) | |
CNS | 12.0 (n = 4) | 1.4 (n = 30) | 9.0 (n = 14) | 2.3 (n = 40) | |
All medicines | 3.0 (n = 21) | 0.9 (n = 114) | 3.8 (n = 71) | 1.4 (n = 167) | |
Upper-middle income countries (n = 8) | Cardiovascular | 3.5 (n = 6) | 0.1 (n = 17) | 1.9 (n = 39) | 0.3 (n = 55) |
Diabetes | 2.1 (n = 2) | 0.3 (n = 6) | 1.4 (n = 14) | 0.5 (n = 22) | |
COPD | 0.6 (n = 1) | 0.3 (n = 3) | 1.5 (n = 9) | 0.6 (n = 12) | |
CNS | - | 0.4 (n = 10) | 4.0 (n = 28) | 0.9 (n = 32) | |
All medicines | 2.8 (n = 9) | 0.2 (n = 36) | 2.4 (n = 90) | 0.5 (n = 121) |
*Based on median treatment prices and the daily wage of the lowest paid unskilled government worker. Excludes medicines supplied free-of-charge in the public sector. n = number of data points in the analysis